CDX2 and adenocarcinoma: This is similar to a previous report in which CDX2 positivity was observed in 4 out of 4 cases of adenocarcinoma of the duodenum and 18 of 30 cases of SBA (Werling et al, 2003; Zhang et al, 2007).